We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Authors » Debra M. Emerson

Debra M. Emerson

Products

PRODUCTS

CSL Behring, LLC

Debra M. Emerson, Claire M. Minden, and Prabhu P. Raju
$117.00
View

Emergent Manufacturing Operations Baltimore, LLC

Debra M. Emerson, Cody D. Rickman, and Jeremy Wally
$117.00
View

bluebird bio, Inc.

Debra M. Emerson and Alice C. Silva
$117.00
View

Genzyme Polyclonals SAS

Debra M. Emerson and Eileen A. Liu
$117.00
View

GenTrac, Inc.

Debra M. Emerson, Peter Kessler, and Ze Peng
$117.00
View

Wyeth BioPharma, Division of Wyeth Pharmaceuticals, Inc.

Debra M. Emerson
$117.00
View

CSL Behring LLC

Debra M. Emerson and Susan M. Jackson
$117.00
View

Barr Laboratories, Inc.

Debra M. Emerson
$117.00
View

Novo Nordisk A/S

Debra M. Emerson and Simone E. Pitts
$117.00
View

GlaxoSmithKline Biologicals

Debra M. Emerson, Dino A. Feigelstock, and Omotunde O. Osunsanmi
$117.00
View
View All Products by Debra M. Emerson

Upcoming Events

  • 13Jul

    FDA Ad and Promo Enforcement Trends: Past, Present and Future

  • 27Jul

    Applying the Lessons of the Pandemic to Your Upcoming Trial

  • 28Jul

    EU-MDR’s Growing Pains: Are You Current with the Latest Developments?

  • 02Aug

    Medical Device Cybersecurity: Understand the Latest Developments

  • 03Aug

    Pharmaceutical Process Validation: Best Practices for Success

  • 10Aug

    Gene & Cell Therapy Regulation: Comparability and Other New Developments

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • FDA Approves Foundation Medicine’s Companion Diagnostic for Genentech’s Rozlytrek

  • Novartis Pays $100 Million for Mallinckrodt’s Priority Review Voucher

  • FDA Approves Beyond Air’s LungFit PH for Newborn Pulmonary Hypertension

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing